Search results for " blood"

showing 10 items of 1796 documents

Acute inflammatory response after inguinal and incisional hernia repair with implantation of polypropylene mesh of different size.

2005

The purpose of this study was to assess the modifications of interleukin (IL)-6, C-reactive protein (CRP), leukocytes and fibrinogen after implantation of polypropylene mesh.Thirty-six patients were included in this study and divided into two groups. To the first group were allocated patients affected by inguinal hernia and undergoing conventional repair (subgroup Ia) or hernioplasty with 40-cm(2) polypropylene mesh (subgroup Ib). To the second group were allocated patients affected by incisional hernia and undergoing conventional repair (subgroup IIa) or incisional hernia repair with 400-cm(2) polypropylene mesh (subgroup IIb). Peripheral venous blood samples were collected 24 h before sur…

medicine.medical_specialtyIncisional herniaBiocompatible MaterialsHernia InguinalFibrinogenPolypropylenesProsthesis ImplantationmedicineLeukocytesHumansHerniaHerniorrhaphyInflammationbiologybusiness.industryInterleukin-6C-reactive proteinFibrinogenVenous bloodMiddle AgedSurgical Meshmedicine.diseaseSurgeryHernia AbdominalInguinal herniaSurgical meshC-Reactive Proteinbiology.proteinSurgeryFemalebusinessAbdominal surgerymedicine.drugLangenbeck's archives of surgery
researchProduct

Immunomodulatory and Hematopoietic Effects of Recombinant Human Interleukin-6 in Patients with Advanced Renal Cell Cancer

1996

Interleukin-6 (IL-6) is a cytokine with pleiotropic biologic activities on B cells, T cells, and hematopoietic progenitors. The present study was undertaken to assess pharmacodynamic effects of subcutaneous administration of IL-6 on blood counts, immunologic parameters, and acute-phase reactants. Blood samples were taken from patients with advanced renal cell cancer participating in a phase II trial of recombinant human IL-6. Multiparameter FACS analyses of peripheral blood mononuclear cells were performed using antibodies against CD3, CD4, CD8, HLA-DR, CD56, CD28, CD38, CD19, sIgM, and sIgG. Serum levels of IL-10, soluble CD23 (sCD23), sCD25, IL-1 receptor antagonist protein (IL-1RA), solu…

medicine.medical_specialtyInjections Subcutaneousmedicine.medical_treatmentImmunologyPeripheral blood mononuclear cellCD19chemistry.chemical_compoundImmunophenotypingAdjuvants ImmunologicVirologyInternal medicinemedicineHumansAcute-Phase ReactionCarcinoma Renal CellbiologyInterleukin-6business.industryCD23NeopterinCell BiologyKidney NeoplasmsRecombinant ProteinsBlood Cell CountHematopoiesisHaematopoiesisCytokineEndocrinologychemistryImmunologybiology.proteinbusinessCD8Journal of Interferon & Cytokine Research
researchProduct

Is losartan able to improve renal haemodynamics in hypertensives? a long term study

2000

medicine.medical_specialtyKidneybusiness.industryHemodynamicsRenal functionRenal haemodynamicsLosartanmedicine.anatomical_structureBlood pressureRenal blood flowInternal medicineInternal MedicineCardiologyVascular resistanceMedicinebusinessmedicine.drugAmerican Journal of Hypertension
researchProduct

Transfusion transmitted leishmaniasis. What to do with blood donors from endemic areas?

2014

Summary Leishmaniasis clinical spectrum ranges from cryptic infection to fatal visceral leishmaniasis. Cryptic infection can be found in blood donors from areas endemic for leishmaniasis all over the world. Although leishmaniasis is a classic vector-borne disease, cases of transfusion transmitted leishmaniasis have been reported especially in nonendemic areas. Most of these cases regarded infants or children. This paper reviews the literature on this specific feature and the impact of leishmaniasis on transfusion medicine. Relevant literature was found through PubMed. The reference lists of selected articles identified further sources. Conclusions: Blood donations by emigrants or travelers f…

medicine.medical_specialtyLeishmaniasiSettore MED/09 - Medicina InternaBlood DonorsDiseaseBlood donationsmedicineAnimalsHumansTravel medicineBlood TransfusionIntensive care medicineLeishmaniabiologyTransfusion Medicinebusiness.industryPublic Health Environmental and Occupational HealthTransfusion medicineLeishmaniasismedicine.diseaseLeishmaniabiology.organism_classificationtransfusion blood donorCryptic infectionBloodInfectious DiseasesVisceral leishmaniasisLeishmaniasis; transfusion blood donors;ImmunologyLeishmaniasis Visceralbusiness
researchProduct

A leptin missense mutation associated with hypogonadism and morbid obesity

1998

medicine.medical_specialtyLeptin DeficiencyInsulin bloodGenetics of obesityLeptinBiologymedicine.diseaseObesityMorbid obesityEndocrinologyInternal medicineMutation (genetic algorithm)GeneticsmedicineMissense mutationNature Genetics
researchProduct

Hyperuricemia and non-dipping blood pressure

2013

Dear editor The strong association between the metabolic derangements that characterize the metabolic syndrome with arterial hypertension is very well-known, as it is the common finding of hyperuricemia in the patients with the metabolic syndrome. Besides, hyperuricemia has been found to be associated with cardiovascular, renal, and metabolic diseases; including not only gout but also type 2 diabetes mellitus, although its role as a risk factor is still debated.1 We were not aware of previous studies describing an association between uric acid levels and the non-dipping 24-hour blood pressure (BP) pattern, and for that reason we were intrigued by Tutal et al’s article, regarding hypertensiv…

medicine.medical_specialtyLetterInternational Journal of Nephrology and Renovascular Disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineHyperuricemiasleep apnea blood pressure uric acidbusiness.industrymedicine.disease3. Good healthGoutObstructive sleep apneaEndocrinologyBlood pressure030228 respiratory systemchemistryNephrologyUric acidMetabolic syndromebusinessHypopnea030217 neurology & neurosurgeryDyslipidemiaInternational Journal of Nephrology and Renovascular Disease
researchProduct

Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma

2020

Daratumumab is a human CD38-targeted monoclonal antibody approved as monotherapy for heavily pretreated relapsed and refractory multiple myeloma. We report findings for the Spanish cohort of an open-label treatment protocol that provided early access to daratumumab monotherapy and collected safety and patient-reported outcomes data for patients with relapsed or refractory multiple myeloma. At 15 centers across Spain, intravenous daratumumab (16 mg/kg) was administered to 73 patients who had >= 3 prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug, or who were double refractory to both. The median duration of daratumumab treatment was 3.3 (range: 0.03-13.17)…

medicine.medical_specialtyLeukopenialcsh:RC633-647.5business.industryAnemiaDaratumumablcsh:Diseases of the blood and blood-forming organsHematologyNeutropeniamedicine.disease002ArticleClinical trialRefractoryInternal medicineProteasome inhibitormedicinemedicine.symptombusinessAdverse effectmedicine.drugHemaSphere
researchProduct

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

2013

Substantial improvements in the safety of blood and plasma products for the management of bleeding disorders have been achieved in recent decades. This has led some clinicians to believe that the infectious threat is over and that inhibitor formation is the foremost complication of hemophilia therapy. On the contrary, elimination of all microbes from blood is difficult, potentially impossible, and there are always threats from emerging pathogens. The risk of infection transmission is also increasing due to greater exposure to products, increasing prophylaxis and high-dose regimens for immune tolerance, and longevity of hemophilia patients. Current products can be considered "reasonably safe…

medicine.medical_specialtyLong term treatmentContext (language use)Hemophilia AInfectionsEmerging infectionsSAFERHumans; Blood Coagulation Disorders; Hemophilia A; Blood Transfusion; InfectionmedicineHumansBlood TransfusionIntensive care medicinePathogenTransmission (medicine)business.industryRisk of infectionTransfusion ReactionHematologyBlood Coagulation Disordersmedicine.diseaseSettore MED/07 - Microbiologia e Microbiologia ClinicaThrombosisSurgeryHemostasisPlasma productsBlood safetyCardiology and Cardiovascular MedicinebusinessInfectionSeminars in thrombosis and hemostasis
researchProduct

Bowel resection reduces aortic pulse wave velocity in patients with ulcerative colitis. A longitudinal study.

2020

NA

medicine.medical_specialtyLongitudinal studySettore MED/09 - Medicina Internamedicine.medical_treatmentInflammationBlood PressurePulse Wave AnalysisInflammatory bowel diseaseGastroenterologyInflammatory bowel diseaseVascular StiffnessInternal medicineInternal MedicinemedicineHumansIn patientLongitudinal StudiesPulse wave velocityArterial stiffness Inflammation Inflammatory bowel disease Pulse wave velocity Blood Flow Velocity Blood Pressure Humans Longitudinal Studies Pulse Wave Analysis Colitis Ulcerative Vascular StiffnessInflammationbusiness.industryBowel resectionmedicine.diseaseUlcerative colitisArterial stiffnessPulse wave velocityArterial stiffnessColitis Ulcerativemedicine.symptombusinessBlood Flow VelocityEuropean journal of internal medicine
researchProduct

Relationship between metabolic syndrome and aortic stiffness in untreated hypertensive patients

2005

medicine.medical_specialtyMean arterial pressureAmbulatory blood pressurebusiness.industrymedicine.diseaseBlood pressureDiabetes mellitusInternal medicineHeart rateInternal MedicinemedicineCardiologyAortic stiffnessMetabolic syndromebusinessPulse wave velocityAmerican Journal of Hypertension
researchProduct